Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
Health Technology Assessment (Winchester, England)
|
August 26, 2020
Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
Mark Corbett, Ana Duarte, Alexis Llewellyn, et al.
Allergy and Asthma Proceedings
|
September 17, 2025
Baseline disease characteristics among patients with chronic rhinosinusitis with nasal polyps in AROMA: A global registry study
Anju T Peters, Rachna Shah, Enrico Heffler, et al.
Human Molecular Genetics
|
July 16, 2020
A synonymous UPF3B variant causing a speech disorder implicates NMD as a regulator of neurodevelopmental disorder gene networks
Deepti Domingo, Urwah Nawaz, Mark Corbett, et al.
Health Technology Assessment (Winchester, England)
|
October 5, 2017
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
Mark Corbett, Fadi Chehadah, Mousumi Biswas, et al.
Advances in Therapy
|
September 27, 2025
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies
Martin Desrosiers, Scott Nash, Andrew Lane, et al.
Health Technology Assessment (Winchester, England)
|
February 16, 2026
Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis
Mark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 18, 2025
The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS
Matthew Walton, Nyanar Jasmine Deng, Mark Corbett, et al.
Advances in Therapy
|
December 24, 2025
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies
Martin Desrosiers, Scott Nash, Andrew Lane, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2025
Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis
Mark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt, et al.
Gait & Posture
|
September 8, 2023
Clinical Movement Analysis Society - UK and Ireland: Clinical Movement Analysis Standards
Caroline Stewart, Linda Eve, Sally Durham, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
Health Technology Assessment (Winchester, England)
|
August 26, 2020
Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
Mark Corbett, Ana Duarte, Alexis Llewellyn, et al.
Allergy and Asthma Proceedings
|
September 17, 2025
Baseline disease characteristics among patients with chronic rhinosinusitis with nasal polyps in AROMA: A global registry study
Anju T Peters, Rachna Shah, Enrico Heffler, et al.
Human Molecular Genetics
|
July 16, 2020
A synonymous UPF3B variant causing a speech disorder implicates NMD as a regulator of neurodevelopmental disorder gene networks
Deepti Domingo, Urwah Nawaz, Mark Corbett, et al.
Health Technology Assessment (Winchester, England)
|
October 5, 2017
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
Mark Corbett, Fadi Chehadah, Mousumi Biswas, et al.
Advances in Therapy
|
September 27, 2025
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies
Martin Desrosiers, Scott Nash, Andrew Lane, et al.
Health Technology Assessment (Winchester, England)
|
February 16, 2026
Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis
Mark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 18, 2025
The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS
Matthew Walton, Nyanar Jasmine Deng, Mark Corbett, et al.
Advances in Therapy
|
December 24, 2025
Correction to: Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 Studies
Martin Desrosiers, Scott Nash, Andrew Lane, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2025
Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis
Mark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt, et al.
Gait & Posture
|
September 8, 2023
Clinical Movement Analysis Society - UK and Ireland: Clinical Movement Analysis Standards
Caroline Stewart, Linda Eve, Sally Durham, et al.
Page
of 9